Request Call Back

Contact Us

No Form
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



   * Please describe your case:

Date of Incident : 

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.


Abilify Side Effects Lawsuits | Side Effects: Diabetes, Fatal Heart-Rhythm Irregularity, Torsade De Pointes, Nausea, Diarrhea

Abilify Side Effects Link To Fatal Heart-Rhythm Lawsuits

Abilify | Lawsuits, Lawyers | Side Effects: Diabetes, Fatal Heart-Rhythm Irregularity, Torsade De Pointes, Nausea, Diarrhea

On April 13, 2004, the FDA instructed Bristol-Myers Squibb to notify health care professionals of a revision to the warnings section of labeling for Abilify (aripiprazole), describing the potential increased risk of hyperglycemia and diabetes in patients taking the drug. In a recent study, atypical antipsychotics similar to Abilify were found to cause diabetes 50 percent more often than older drugs.

Abilify is used to treat schizophrenia and is part of a class of drugs known as atypical antipsychotics. It is in the same class as Zyprexa, Risperdal and Seroquel. The U.S. Food and Drug Administration approved Abilify for the treatment of schizophrenia on November 15, 2002.

The FDA has become concerned about the possibility that Ziprasidone, a drug similar to Abilify, and a number of other drugs might increase the possibility of a specific, and potentially fatal heart-rhythm irregularity called torsade de pointes.

Additional Abilify side effects include: being unusually tired, nausea, constipation, dizziness, restlessness, diarrhea, rash, cough, runny nose, abnormal muscle movements, tremors, and uncontrollable movements.

Abilify and Pathological Gambling

Research suggests that the use of Abilify could induce or worsen pathological gambling. This type of addictive behavior could potentially lead to severe financial loss, relationship issues, and legal problems. Abilify is believed to regulate mood and behavior in patients with psychosis by affecting levels of dopamine and serotonin. Researchers believe that Abilify may influence compulsive behavior by over-stimulating dopamine receptions in the brain, intensifying the reward system.

In April 2011, the British Journal of Psychiatry published a paper citing three case studies in which patients taking Abilify noted an increase in gambling behavior once treatment began. In one case, one patient had a 12-year history of gambling behavior. After starting Abilify he reported an increase in gambling behavior and "was pre-occupied with thoughts of gambling and his gambling activity became both impulsive and involved extensive planning in obtaining funds to gamble, including the use of crime," the paper stated. After being switched to a different medication, the patient said he no longer had ongoing thoughts or plans to gamble; this was maintained at the 6-month follow-up. Another patient taking Abilify to treat schizoaffective disorder said gambling became "a reason to live" after taking the medication for 3 months. Prior to treatment, he had been spending about half his money on gambling. Upon taking Abilify, he started spending all of his money. He was changed to a different medication following a recommendation from his psychiatrist; this had a "massive impact" on his gambling. At the 3-month follow-up, after Abilify was stopped, he reported no compulsion to gamble and only played once per week. A third patient had no history of gambling before treatment with Abilify. About one year after being treated with Abilify, he reported "experiencing strong urges to gamble in the form of a euphoric feeling when thinking about gambling. In the following 2 years he incurred debts of around £25 000 on Internet betting sites." The patient was taken off the medication and had no urge to gamble 1 month later. This abstinence from gambling persisted at both the 3- and 6-month follow-ups.

Pathological gambling was also reported among Abilify patients in a paper published in Addictive Behaviors in 2013. The authors stated that dopamine replacement therapy is one of the risk factors influencing pathological gambling because it may act on the dopamine receptor in the limbic system (D3) and over-stimulate the reward system.

In December 2014, JAMA Internal Medicine published a study showing that dopamine receptor agonist drugs, such as Abilify, are associated with pathological gambling, hypersexuality and compulsive shopping and discussed the drug approval and warnings involving the U.S. Food and Drug Administration (FDA). "Our findings confirm and extend the evidence that dopamine receptor agonist drugs are associated with these specific impulse control disorders. At present, none of the dopamine receptor agonist drugs approved by the FDA have boxed warnings as part of their prescribing information. Our data, and data from prior studies, show the need for more prominent warnings," the authors wrote.

Legal Help For Victims Affected By Abilify

If you or a loved one took Abilify and suffered side effects, please fill out the form at the right for a free case evaluation by a qualified drug side effects attorney or call us at 1-800-YOURLAWYER (1-800-968-7529).


AbilifyRSS Feed

Atypical Antipsychotics Linked to Worrisome Weight Gains, Other Outcomes, in Children

Oct 28, 2009 | Parker Waichman LLP
Yet another study has linked significant weight gains in children to some antipsychotic medication. Forbes reported that an emerging study found that weight gains of 10-to-20 pounds were not unusual in children during their first three months on the medications like Zyprexa, Seroquel, Risperdal and Abilify. Also, cholesterol, triglyceride, and other metabolic “parameters” were elevated, said Forbes.It has long been known and we have long written about the association between weight...

American Children Take the Most Psychotropic Drugs

Sep 26, 2008 | Parker Waichman LLP
A new study reports that American children are about three times likelier to be prescribed psychotropic medications than children in Europe.  The study states that the differences may be attributable to regulatory practices and cultural beliefs about the role of medication in emotional and behavioral problems.Julie Zito led the team comprised of researchers from the U.S., Germany, and the Netherlands.  The group investigated prescription levels in the three countries.  Zito...

Atypical Antipsychotic Drugs Used Inappropriately, Prescribed too Often, Critics Charge

Feb 18, 2008 | Parker Waichman LLP
Zyprexa, Seroquel, Abilify and other atypical antipsychotic drugs, meant to be used sparingly for severe mental illness like schizophrenia and bi-polar disorder, are being prescribed in increasing numbers to young children and the elderly.  Doctors have helped to turn atypical antipsychotics like Zyprexa into blockbusters by prescribing them for more common conditions such as dementia and aggression.  Some have accused drug makers of illegally promoting off-label uses as the reason...

Bristol Myers Squibb to Pay $515 Million for Kickbacks, Off-Label Marketing and Price Fixing Schemes

Oct 1, 2007 | Parker Waichman LLP
Bristol Myers Squibb and its affiliate Apothecon, Inc. paid kickbacks to physicians for prescribing the company’s drugs and illegally promoted the off-label use of the anti-psychotic drug Abilify.  Now, Bristol Myers Squibb has agreed to pay more than $500,000 to settle a civil suit that stemmed from those and other illegal practices.The settlement was announced by the US Attorneys Office in Massachusetts.  Under the terms of the settlement, Bristol Myers Squibb will pay the pay...

Adult anti-psychotics can worsen troubles

May 2, 2006 | USA Today
Evan Kitchens, a cheerful fourth-grader who loves basketball and idolizes his 16-year-old brother, had been hospitalized for mental illness by the time he was 8. The boy from Bandera, Texas, was aggressive and hyperactive and had been diagnosed with a variety of other ailments, including obsessive-compulsive disorder and an autism spectrum disorder. A couple of years ago, Evan was taking five psychiatric drugs, says his mother, Mary Kitchens. Two were so-called atypical anti-psychotics, a...

More Abilify News

Parker Waichman Accolades And Reviews Law Dragon Best Lawyers Find Us On Avvo